299. Cystic fibrosis Clinical trials / Disease details


Clinical trials : 1,696 Drugs : 1,644 - (DrugBank : 272) / Drug target genes : 96 - Drug target pathways : 170

  
3 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT02398383
(ClinicalTrials.gov)
March 201522/1/2015Role of Glucagon In Glucose Control in Cystic Fibrosis Related DiabetesRole of Glucagon in Glucose Control in Cystic Fibrosis Related DiabetesCystic Fibrosis;Cystic Fibrosis Related DiabetesOther: Oral Glucose Tolerance Test;Other: Mixed Meal Tolerance Test;Other: Hypoglycemic ClampYale UniversityNULLCompleted12 Years45 YearsAll7Early Phase 1United States
2NCT02202876
(ClinicalTrials.gov)
November 201425/7/2014Redox Imbalance and the Development of Cystic Fibrosis DiabetesRedox Imbalance and the Development of Cystic Fibrosis DiabetesDiabetes Mellitus, Type 2;Cystic FibrosisOther: Oral Glucose Tolerance Test;Other: High Glycemic Index Meal;Other: Low Glycemic Index Meal;Other: Test Soda;Other: Fruit juiceEmory UniversityCystic Fibrosis FoundationCompleted1 YearN/AAll34N/AUnited States
3NCT03644199
(ClinicalTrials.gov)
March 30, 201110/5/2016Development of Diabetes in Adults With Cystic Fibrosis (CF)Factors Responsible for the Development of Diabetes in Adults With Cystic FibrosisCystic FibrosisOther: Oral Glucose Tolerance Test (OGTT) assessment arm;Other: Mixed meal test evaluation test armLiverpool Heart and Chest Hospital NHS Foundation TrustNULLWithdrawn18 Years50 YearsAll0N/AUnited Kingdom